21 Aug 2024
8m
Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People | Bloomberg Businessweek
Bloomberg Podcasts
Open in Podwise to generate AI notes
Sign in to process this episode and unlock summaries, transcripts, highlights and translations.
Shownotes are not generated by Podwise.